Owens & Minor, Inc. Q2 2025 Earnings Recap

Owens & Minor reported robust growth in its Patient Direct business amid the planned divestiture of its Products & Healthcare Services segment, positioning the company for future profitability in the evolving home-based care market.

Key Takeaways

• Projected revenue for the Patient Direct segment is expected to reach between $2.76 billion and $2.82 billion in 2025, with adjusted EBITDA ranging from $376 million to $382 million.
• The divestiture process for the Products & Healthcare Services segment is underway, allowing the company to concentrate on the higher-margin, higher-growth Patient Direct business.
• Demographic trends underpinning the demand for home-based care are strong, with substantial growth potential driven by increasing chronic health conditions among American adults.
• Despite the termination of the Rotech acquisition, management remains focused on selective acquisition opportunities to enhance Patient Direct capabilities.
• Initiatives to drive revenue and EBITDA growth include advancements in IT infrastructure, revenue cycle improvements, and an expanded sales force.